Equities Analysts Set Expectations for Enphase Energy Inc’s Q3 2019 Earnings (NASDAQ:ENPH)

Enphase Energy Inc (NASDAQ:ENPH) – Research analysts at Oppenheimer raised their Q3 2019 earnings estimates for shares of Enphase Energy in a research report issued on Wednesday, July 31st, according to Zacks Investment Research. Oppenheimer analyst C. Rusch now anticipates that the semiconductor company will post earnings of $0.23 per share for the quarter, up from their previous forecast of $0.13. Oppenheimer has a “Outperform” rating and a $26.00 price objective on the stock. Oppenheimer also issued estimates for Enphase Energy’s Q4 2019 earnings at $0.25 EPS, FY2019 earnings at $0.60 EPS, FY2020 earnings at $0.97 EPS and FY2021 earnings at $1.20 EPS.

Equities Analysts Issue Forecasts for The Coca-Cola Co’s Q4 2019 Earnings (NYSE:KO)

The Coca-Cola Co (NYSE:KO) – Jefferies Financial Group boosted their Q4 2019 earnings estimates for shares of The Coca-Cola in a report issued on Tuesday, July 23rd, Zacks Investment Research reports. Jefferies Financial Group analyst K. Grundy now expects that the company will post earnings per share of $0.45 for the quarter, up from their previous estimate of $0.43.

Equities Analysts Set Expectations for Agenus Inc’s Q3 2019 Earnings (NASDAQ:AGEN)

Agenus Inc (NASDAQ:AGEN) – Research analysts at B. Riley issued their Q3 2019 earnings estimates for shares of Agenus in a research report issued on Wednesday, August 14th. B. Riley analyst H. Polishetty anticipates that the biotechnology company will earn ($0.52) per share for the quarter. B. Riley has a “Buy” rating and a $5.00 price objective on the stock. B. Riley also issued estimates for Agenus’ Q4 2019 earnings at ($0.30) EPS, FY2019 earnings at ($1.06) EPS, FY2020 earnings at ($0.98) EPS, FY2021 earnings at ($0.67) EPS, FY2022 earnings at ($0.56) EPS and FY2023 earnings at ($0.31) EPS.

Equities Analysts Set Expectations for ASGN Inc’s Q3 2019 Earnings (NYSE:ASGN)

ASGN Inc (NYSE:ASGN) – Equities researchers at William Blair decreased their Q3 2019 earnings per share (EPS) estimates for ASGN in a note issued to investors on Thursday, July 25th, Zacks Investment Research reports. William Blair analyst T. Mchugh now forecasts that the business services provider will earn $1.23 per share for the quarter, down from their prior estimate of $1.27. William Blair also issued estimates for ASGN’s FY2019 earnings at $4.60 EPS, Q1 2020 earnings at $1.04 EPS, Q2 2020 earnings at $1.29 EPS, Q3 2020 earnings at $1.38 EPS and FY2020 earnings at $5.13 EPS.

Equities Analysts Increase Earnings Estimates for First Financial Bankshares Inc (NASDAQ:FFIN)

First Financial Bankshares Inc (NASDAQ:FFIN) – Stock analysts at SunTrust Banks boosted their Q3 2019 earnings estimates for shares of First Financial Bankshares in a research note issued on Monday, July 22nd, according to Zacks Investment Research. SunTrust Banks analyst J. Demba now anticipates that the bank will earn $0.31 per share for the quarter, up from their prior forecast of $0.30. SunTrust Banks also issued estimates for First Financial Bankshares’ Q2 2020 earnings at $0.31 EPS.

Equities Analysts Offer Predictions for Hill-Rom Holdings, Inc.’s FY2021 Earnings (NYSE:HRC)

Hill-Rom Holdings, Inc. (NYSE:HRC) – Equities researchers at KeyCorp issued their FY2021 earnings per share estimates for shares of Hill-Rom in a research note issued to investors on Sunday, August 4th. KeyCorp analyst M. Mishan forecasts that the medical technology company will post earnings per share of $6.25 for the year. KeyCorp currently has a “Overweight” rating and a $125.00 price objective on the stock.

Equities Analysts Set Expectations for Agile Therapeutics Inc’s FY2022 Earnings (NASDAQ:AGRX)

Agile Therapeutics Inc (NASDAQ:AGRX) – Equities researchers at Oppenheimer lowered their FY2022 earnings per share (EPS) estimates for shares of Agile Therapeutics in a research report issued on Monday, August 5th. Oppenheimer analyst L. Gershell now expects that the specialty pharmaceutical company will post earnings of $1.34 per share for the year, down from their prior forecast of $1.38. Oppenheimer has a “Outperform” rating and a $5.00 price target on the stock. Oppenheimer also issued estimates for Agile Therapeutics’ FY2023 earnings at $1.71 EPS.

Equities Analysts Lower Earnings Estimates for Viper Energy Partners LP (NASDAQ:VNOM)

Viper Energy Partners LP (NASDAQ:VNOM) – Equities researchers at Capital One Financial dropped their Q3 2019 earnings per share (EPS) estimates for shares of Viper Energy Partners in a report released on Monday, August 5th. Capital One Financial analyst K. May now expects that the oil and gas producer will post earnings per share of $0.07 for the quarter, down from their prior forecast of $0.09. Capital One Financial has a “Overweight” rating and a $37.00 price target on the stock. Capital One Financial also issued estimates for Viper Energy Partners’ Q4 2019 earnings at $0.22 EPS and Q4 2020 earnings at $0.17 EPS.

Equities Analysts Lift Earnings Estimates for Home Depot Inc (NYSE:HD)

Home Depot Inc (NYSE:HD) – Equities research analysts at Jefferies Financial Group lifted their Q2 2020 earnings estimates for shares of Home Depot in a research report issued to clients and investors on Thursday, July 11th, Zacks Investment Research reports. Jefferies Financial Group analyst J. Matuszewski now anticipates that the home improvement retailer will post earnings per share of $3.01 for the quarter, up from their prior forecast of $2.97. Jefferies Financial Group also issued estimates for Home Depot’s FY2020 earnings at $10.08 EPS and FY2021 earnings at $10.79 EPS.

error: Content is protected !!